| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.75B | +9.7% |
| Cost of Revenue | $2.56B | +9.4% |
| R&D Expense | $354.0M | +12.7% |
| SG&A Expense | $620.0M | +2.8% |
| Interest Expense | $65.0M | — |
| Pre-tax Income | $962.0M | +6.8% |
| Income Tax | $233.0M | +31.6% |
| Net Income | $729.0M | +0.7% |
| EPS (Basic) | $3.30 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $915.0M | +451.2% |
| Accounts Receivable | $656.0M | +13.1% |
| Inventory | $661.0M | +10.7% |
| Current Assets | $2.64B | +77.9% |
| Total Assets | $14.07B | +14.6% |
| Current Liabilities | $1.36B | +61.6% |
| Long-term Debt | $4.10B | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.27B | +20.0% |
| Investing Cash Flow | -$285.0M | -65.7% |
| Financing Cash Flow | -$248.0M | +70.8% |
| -0.3% |
| EPS (Diluted) | $3.30 | -0.3% |
| Total Liabilities |
| $6.70B |
| +386.9% |
| Stockholders' Equity | $7.09B | -33.3% |